Review: could Revlimid cause Embolic Stroke?


Summary

Embolic stroke is found among people who take Revlimid, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Aciphex, and have Multiple myeloma . We study 57,755 people who have side effects while taking Revlimid from FDA and social media. Among them, 10 have Embolic stroke. Find out below who they are, when they have Embolic stroke and more.

You are not alone

Join a support group for people who take Revlimid and have Embolic stroke >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Revlimid

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. (latest outcomes from Revlimid 64,433 users)

Embolic Stroke

Embolic stroke (stroke due to obstruction due to an embolus) has been reported by people with brain natriuretic peptide increased, urinary tract infection, diarrhea, ophthalmoplegia, pancytopenia (latest reports from 1,642 Embolic stroke patients).

On Aug, 28, 2016

57,755 people reported to have side effects when taking Revlimid.
Among them, 10 people (0.02%) have Embolic Stroke


Number of reports submitted per year:

Could Revlimid cause Embolic stroke?

Time on Revlimid when people have Embolic Stroke *:

  • < 1 month: 83.33 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Embolic Stroke when taking Revlimid *:

  • female: 40 %
  • male: 60 %

Age of people who have Embolic Stroke when taking Revlimid *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 80 %

Top conditions involved for these people *:

  • Multiple Myeloma (5 people)
  • Myelodysplastic Syndrome (4 people)
  • Plasma Cell Myeloma (1 person)
  • Pain (1 person)
  • Blood Pressure Increased (1 person)

Top co-used drugs for these people *:

  • Oxytrol (3 people)
  • K-Dur (3 people)
  • Aspirin (3 people)
  • Apap Tab (3 people)
  • Aciphex (3 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Embolic stroke when taking Revlimid?

Browse all side effects of Revlimid

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Embolic stroke

Embolic stroke

Could your condition cause Embolic stroke

Embolic stroke

Can you answer these questions?

More questions for: Revlimid, Embolic stroke

You may be interested in these reviews

More reviews for: Revlimid, Embolic stroke


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.